| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/HEP.28574 |
| P8608 | Fatcat ID | release_vluznv4edbhstgkblvlcwo3xve |
| P3181 | OpenCitations bibliographic resource ID | 3765234 |
| P932 | PMC publication ID | 4956496 |
| P698 | PubMed publication ID | 27015352 |
| P2093 | author name string | Daolin Tang | |
| Rui Kang | |||
| De Chen | |||
| Xiaofang Sun | |||
| Xiaohua Niu | |||
| Wenyin He | |||
| Ruochan Chen | |||
| P2860 | cites work | Role of Nrf2 in oxidative stress and toxicity | Q23919669 |
| Sorafenib in advanced hepatocellular carcinoma | Q27861075 | ||
| HSPB1 as a novel regulator of ferroptotic cancer cell death | Q28258033 | ||
| Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice | Q28396141 | ||
| Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells | Q28397198 | ||
| Cancer statistics, 2016 | Q29547383 | ||
| Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial | Q29547903 | ||
| Hepatocellular carcinoma | Q29615765 | ||
| Pharmacological inhibition of cystine-glutamate exchange induces endoplasmic reticulum stress and ferroptosis | Q33745283 | ||
| Regulation of ferroptotic cancer cell death by GPX4 | Q33826380 | ||
| PKM2 regulates the Warburg effect and promotes HMGB1 release in sepsis | Q33926167 | ||
| Ferroptosis: an iron-dependent form of nonapoptotic cell death | Q34032093 | ||
| The role of iron and reactive oxygen species in cell death | Q34039363 | ||
| Sorafenib induces ferroptosis in human cancer cell lines originating from different solid tumors. | Q34042349 | ||
| Ferroptosis as a p53-mediated activity during tumour suppression | Q34043533 | ||
| T cell lipid peroxidation induces ferroptosis and prevents immunity to infection. | Q34043611 | ||
| Loss of cysteinyl-tRNA synthetase (CARS) induces the transsulfuration pathway and inhibits ferroptosis induced by cystine deprivation | Q34044497 | ||
| Ferroptosis: Death by Lipid Peroxidation | Q34045575 | ||
| Ferroptosis: process and function | Q34045909 | ||
| Isolation and culture of primary hepatocytes from resected human liver tissue | Q34127014 | ||
| Synchronized renal tubular cell death involves ferroptosis. | Q34447203 | ||
| Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism | Q34534013 | ||
| Metallothioneins and cancer | Q34610906 | ||
| Metallothionein: the multipurpose protein | Q34648045 | ||
| Sorafenib inhibits proliferation and invasion of human hepatocellular carcinoma cells via up-regulation of p53 and suppressing FoxM1. | Q35080145 | ||
| The nuclear function of p53 is required for PUMA-mediated apoptosis induced by DNA damage | Q35676779 | ||
| High-mobility group box 1 is essential for mitochondrial quality control | Q35800479 | ||
| High-mobility group box 1 activates caspase-1 and promotes hepatocellular carcinoma invasiveness and metastases | Q36175681 | ||
| Identification of retinoic acid as an inhibitor of transcription factor Nrf2 through activation of retinoic acid receptor alpha | Q36288735 | ||
| Metallothionein expression is suppressed in primary human hepatocellular carcinomas and is mediated through inactivation of CCAAT/enhancer binding protein alpha by phosphatidylinositol 3-kinase signaling cascade | Q36512697 | ||
| The role of metallothioneins in anticancer drug resistance | Q36546717 | ||
| Sorafenib: where do we go from here? | Q36708741 | ||
| Metallothionein - immunohistochemical cancer biomarker: a meta-analysis | Q37453240 | ||
| The role of metallothionein in oxidative stress | Q38090395 | ||
| Toward clinical application of the Keap1-Nrf2 pathway | Q38105775 | ||
| New biological perspectives for the improvement of the efficacy of sorafenib in hepatocellular carcinoma | Q38174980 | ||
| Regulated necrosis: disease relevance and therapeutic opportunities | Q38699324 | ||
| Iron-dependent cell death of hepatocellular carcinoma cells exposed to sorafenib | Q39179266 | ||
| Hypoxia-mediated sorafenib resistance can be overcome by EF24 through Von Hippel-Lindau tumor suppressor-dependent HIF-1α inhibition in hepatocellular carcinoma. | Q39214063 | ||
| Inhibition of the Nrf2 transcription factor by the alkaloid trigonelline renders pancreatic cancer cells more susceptible to apoptosis through decreased proteasomal gene expression and proteasome activity | Q39251887 | ||
| High-yield preparation of isolated rat liver parenchymal cells: a biochemical and fine structural study | Q41115222 | ||
| Loss of metallothionein predisposes mice to diethylnitrosamine-induced hepatocarcinogenesis by activating NF-kappaB target genes | Q42699492 | ||
| Increased expression of metallothionein is associated with irinotecan resistance in gastric cancer | Q44980763 | ||
| Identification and Successful Negotiation of a Metabolic Checkpoint in Direct Neuronal Reprogramming | Q49020427 | ||
| Detection of metallothionein 1G as a methylated tumor suppressor gene in human hepatocellular carcinoma using a novel method of double combination array analysis. | Q51564639 | ||
| Inhibition of glutathione synthesis with propargylglycine enhances N-acetylmethionine protection and methylation in bromobenzene-treated Syrian hamsters | Q74615654 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | ferroptosis | Q24466962 |
| P304 | page(s) | 488-500 | |
| P577 | publication date | 2016-08-01 | |
| P1433 | published in | Hepatology | Q15724398 |
| P1476 | title | Metallothionein-1G facilitates sorafenib resistance through inhibition of ferroptosis | |
| P478 | volume | 64 |
| Q98224259 | A Novel Ferroptosis-related Gene Signature for Overall Survival Prediction in Patients with Hepatocellular Carcinoma |
| Q42346132 | A novel PINK1- and PARK2-dependent protective neuroimmune pathway in lethal sepsis |
| Q96431730 | ACSL4 is a predictive biomarker of sorafenib sensitivity in hepatocellular carcinoma |
| Q90597978 | AMPK-Mediated BECN1 Phosphorylation Promotes Ferroptosis by Directly Blocking System Xc- Activity |
| Q55497286 | Alterations in Cellular Iron Metabolism Provide More Therapeutic Opportunities for Cancer. |
| Q52571263 | Antiapoptotic BCL-2 proteins determine sorafenib/regorafenib resistance and BH3-mimetic efficacy in hepatocellular carcinoma. |
| Q50077576 | Autophagy and Ferroptosis - What's the Connection? |
| Q37141766 | Autophagy promotes ferroptosis by degradation of ferritin |
| Q89924226 | CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer |
| Q92424232 | CRISPR/Cas9 genome-wide screening identifies KEAP1 as a sorafenib, lenvatinib, and regorafenib sensitivity gene in hepatocellular carcinoma |
| Q40333897 | Characterization of ferroptosis in murine models of hemochromatosis. |
| Q55180385 | Chemical and genetic inhibition of STAT3 sensitizes hepatocellular carcinoma cells to sorafenib induced cell death. |
| Q113757955 | Clinical and Biological Significances of a Ferroptosis-Related Gene Signature in Lung Cancer Based on Deep Learning |
| Q92244206 | Clockophagy is a novel selective autophagy process favoring ferroptosis |
| Q47720042 | Emerging Strategies of Cancer Therapy Based on Ferroptosis. |
| Q64232875 | Erastin decreases radioresistance of NSCLC cells partially by inducing GPX4-mediated ferroptosis |
| Q92409791 | Evaluation of MT Family Isoforms as Potential Biomarker for Predicting Progression and Prognosis in Gastric Cancer |
| Q48959837 | FANCD2 protects against bone marrow injury from ferroptosis |
| Q92461230 | Ferroptosis in Carcinoma: Regulatory Mechanisms and New Method for Cancer Therapy |
| Q90383775 | Ferroptosis is a lysosomal cell death process |
| Q64266344 | Ferroptosis is governed by differential regulation of transcription in liver cancer |
| Q46292537 | Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease |
| Q103836887 | Ferroptosis: molecular mechanisms and health implications |
| Q89518302 | Ferroptosis: past, present and future |
| Q38719048 | HSPA5 Regulates Ferroptotic Cell Death in Cancer Cells |
| Q100332790 | Heat Shock Proteins: Endogenous Modulators of Ferroptosis |
| Q52583858 | Hepatocellular Carcinoma-associated Protein TD26 Interacts and Enhances SREBP1 Activity to Promote Tumor Cell Proliferation and Growth. |
| Q64091327 | Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Opportunities and Challenges |
| Q33728138 | Inhibition of the prolyl isomerase Pin1 enhances the ability of sorafenib to induce cell death and inhibit tumor growth in hepatocellular carcinoma |
| Q98734144 | Insight Into the Role of Ferroptosis in Non-neoplastic Neurological Diseases |
| Q100332993 | Iron Metabolism in Ferroptosis |
| Q48001406 | Iron metabolism and drug resistance in cancer |
| Q38637192 | Iron, Oxidative Damage and Ferroptosis in Rhabdomyosarcoma |
| Q91430007 | Ischemia-induced ACSL4 activation contributes to ferroptosis-mediated tissue injury in intestinal ischemia/reperfusion |
| Q64085279 | Low metallothionein 1M (MT1M) is associated with thyroid cancer cell lines progression |
| Q91302990 | MT1G serves as a tumor suppressor in hepatocellular carcinoma by interacting with p53 |
| Q36292211 | Metallothionein 1H (MT1H) functions as a tumor suppressor in hepatocellular carcinoma through regulating Wnt/β-catenin signaling pathway |
| Q60928897 | Metallothioneins may be a potential prognostic biomarker for tumors: A Prisma-compliant meta-analysis |
| Q97593160 | Molecular Mechanisms of Ferroptosis and Its Role in Pulmonary Disease |
| Q47843948 | Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. |
| Q37597080 | Novel roles of DC-SIGNR in colon cancer cell adhesion, migration, invasion, and liver metastasis |
| Q94560640 | Nrf2 and Ferroptosis: A New Research Direction for Neurodegenerative Diseases |
| Q88723805 | Programmed necrosis in cardiomyocytes: mitochondria, death receptors and beyond |
| Q104569237 | RNA binding protein DAZAP1 promotes HCC progression and regulates ferroptosis by interacting with SLC7A11 mRNA |
| Q53688760 | Recapitulation of pharmacogenomic data reveals that invalidation of SULF2 enhance sorafenib susceptibility in liver cancer. |
| Q100332692 | Regulation and Function of Autophagy During Ferroptosis |
| Q99731951 | Systematic identification of a nuclear receptor-enriched predictive signature for erastin-induced ferroptosis |
| Q64973480 | Targeting Nrf2 to Suppress Ferroptosis and Mitochondrial Dysfunction in Neurodegeneration. |
| Q38719539 | Targeting the PD-L1/DNMT1 axis in acquired resistance to sorafenib in human hepatocellular carcinoma |
| Q37223455 | The Combination of CRISPR/Cas9 and iPSC Technologies in the Gene Therapy of Human β-thalassemia in Mice |
| Q98288733 | The Mechanism of Ferroptosis and Applications in Tumor Treatment |
| Q57809246 | The STING-STAT6 pathway drives Cas9-induced host response in human monocytes |
| Q92463694 | The crosstalk between autophagy and ferroptosis: what can we learn to target drug resistance in cancer? |
| Q97537350 | The emerging role of ferroptosis in non-cancer liver diseases: hype or increasing hope? |
| Q89905976 | The epigenetic regulators and metabolic changes in ferroptosis-associated cancer progression |
| Q90514526 | The ferroptosis inducer erastin promotes proliferation and differentiation in human peripheral blood mononuclear cells |
| Q96348266 | The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects |
| Q92521561 | The microenvironmental and metabolic aspects of sorafenib resistance in hepatocellular carcinoma |
| Q92861156 | The molecular machinery of regulated cell death |
| Q92557070 | The role of ferroptosis in digestive system cancer |
| Q38644809 | The roles of NRF2 in modulating cellular iron homeostasis. |
| Q58713688 | The roles of metallothioneins in carcinogenesis |
| Q54978219 | The tumor suppressor protein p53 and the ferroptosis network. |
| Q89983838 | Transcription factors in ferroptotic cell death |
| Q50590437 | miR-511 promotes the proliferation of human hepatoma cells by targeting the 3'UTR of B cell translocation gene 1 (BTG1) mRNA. |
Search more.